Short Interest in Geron Co. (NASDAQ:GERN) Increases By 5.0% theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Wedbush restated their outperform rating on shares of Geron (NASDAQ:GERN – Free Report) in a research note issued to investors on Tuesday morning, Benzinga reports. They currently have a $6.00 price objective on the biopharmaceutical company’s stock. Separately, Needham & Company LLC reissued a buy rating and set a $4.00 price target on shares of […]
Geron (NASDAQ:GERN – Get Free Report)‘s stock had its “outperform” rating reaffirmed by investment analysts at Wedbush in a report released on Tuesday, Benzinga reports. They presently have a $6.00 price objective on the biopharmaceutical company’s stock. Wedbush’s price objective suggests a potential upside of 152.10% from the company’s previous close. Separately, Needham & Company […]
Geron Co. (NASDAQ:GERN) Receives $5.00 Average Target Price from Brokerages themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Geron Co. (NASDAQ:GERN – Get Rating) saw a significant increase in short interest in the month of May. As of May 31st, there was short interest totalling 28,960,000 shares, an increase of 25.4% from the May 15th total of 23,100,000 shares. Based on an average daily volume of 6,240,000 shares, the short-interest ratio is currently […]